Blaustein Marc

Chief Operating Officer at Finch Therapeutics Group, Inc.

Sold, on record
$7k
Dollars the filings state
Form 4 sales
2
Latest Feb 21, 2023
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Finch Therapeutics Group, Inc.Plan not stated
    Oct 21, 2022 2022

    Sold 3,636 shares at $1.39 ($5k)

    Blaustein Marc, Chief Operating Officer

    Sold 10% of holdings ($50k position)32,614 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Finch Therapeutics Group, Inc.Plan not stated
    Feb 21, 2023 +123 days

    Sold 4,619 shares at $0.38 ($2k)

    Blaustein Marc, Chief Operating Officer

    Sold 14.2% of holdings ($12k position)27,995 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Blaustein Marc
Source
Feb 21, 2023Feb 23, 2023Finch Therapeutics Group, Inc.Chief Operating OfficerForm 4 sale4,619$2k14.2%Plan not statedSEC
Oct 21, 2022Oct 25, 2022Finch Therapeutics Group, Inc.Chief Operating OfficerForm 4 sale3,636$5k10.0%Plan not statedSEC